Papillon Capital LLC

Total investments

2

Average round size

2M

Portfolio companies

2

Rounds per year

0.22

Lead investments

2

Areas of investment
BiotechnologyDiscovery Tools (Healthcare)Health CareHealth DiagnosticsGeneticsMedicalBuilding MaterialConstruction

Summary

Papillon Capital LLC appeared to be the VC, which was created in 2012.

Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. Among the most popular fund investment industries, there are Genetics, Health Care. Among the most popular portfolio startups of the fund, we may highlight MedGenome Inc..

The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2014.

The usual cause for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Vidinovo, Emerge Ventures, Singapore. In the next rounds fund is usually obtained by Sequoia Capital India, Zodius Capital, Sofina.

The overall number of key employees were 3.

Show more

Investments analytics

Analytics

Total investments
2
Lead investments
2
Rounds per year
0.22
Investments by industry
  • Health Diagnostics (1)
  • Medical (1)
  • Genetics (1)
  • Health Care (1)
  • Biotechnology (1)
  • Show 3 more
Investments by region
  • India (2)
Peak activity year
2012

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Group Appearance index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
WorldHaus 01 Nov 2012 Building Material, Construction Seed 0 Karnataka, Bengaluru, India
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.